Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Pharmacy Services

Dáil Éireann Debate, Tuesday - 20 January 2026

Tuesday, 20 January 2026

Ceisteanna (957)

Cormac Devlin

Ceist:

957. Deputy Cormac Devlin asked the Minister for Health the enforcement and compliance framework in place to ensure that pharmacies display, in a conspicuous location, the required information on professional service fees and the range of dispensing fees; the respective roles of the PSI and her Department; the actions that may follow where a pharmacy is found not to be compliant, including any sanctions or escalation pathways; and if she will make a statement on the matter. [3929/26]

Amharc ar fhreagra

Freagraí scríofa

PSI, as the pharmacy regulator, has powers of inspection for pharmacies. It derives inspection authority from the provisions of Part 7 of the Pharmacy Act, which provides the spectrum and range of actions used for the purposes of ascertaining whether any offence under a relevant enactment, any breach of a code of conduct or any professional misconduct has been committed. Differing formats of inspections are utilised, and visits may be focused on a particular area or the general operation of the pharmacy, including inspection/compliance history, and may include systems inspections, focused/thematic inspections or re-inspections to a pharmacy where required.

Since the introduction of the guidance on pricing transparency, compliance has been assessed during 27 inspection visits, with 19 pharmacies displaying a pricing transparency notice for patients and the public. Pharmacies found to be non-compliant are required to confirm compliance within a specified timeframe.

PSI recognises that while pharmacists were always obliged to give honest, relevant and accurate information regarding the costs, benefits and risks of medicinal products, non-medicinal products and services, this recent guidance requires proactive action, which needs to be supported by tools, such as changes to pharmacy software. The PSI has therefore committed to partnering with the sector in delivering on the requirements and to sharing “use and learn” approaches. Engagement with stakeholders, including software providers and the management of queries to support implementation, is ongoing.

PSI, as the statutory regulator, notes adherence by the sector in respect of any guidance issued and engages and monitors adherence to the legislative, professional and ethical obligations inherent in the practice of the profession. The investigative powers and complaints, Inquiries and disciplinary provisions are provided for in Part 6 and Part 7 of the Pharmacy Act

The Registrar considers significant issues identified during an inspection or an investigation under Section 71 of the Pharmacy Act 2007. This is a function designated to the Registrar by the Council. The Registrar has a number of options available including; to take no action [under Section 71(1)(a)], to commence disciplinary proceedings/make a formal complaint [under Section 71(1)(b)], or to take such other actions [under Section 71(1)(d)] as the Registrar considers appropriate in the circumstances.

My Department has oversight function for the PSI, to ensure the PSI delivers on its functions and remit.

Roinn